Impact Biomedical (IBO) Minority Interest (2022 - 2026)

Impact Biomedical (IBO) has reported Minority Interest for 5 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Minority Interest rose 9.63% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2026 stood at $3.2 million (up 9.63% YoY), and the FY2025 full-year result was $3.2 million, up 8.93% from the prior year.
• Minority Interest was little changed at $3.2 million in Q2 2026 per IBO's latest filing, from $3.2 million in the prior quarter.
• Across five years, Minority Interest topped out at $3.2 million in Q1 2026 and bottomed at $3.0 million in Q3 2025.
• Historically, Minority Interest has averaged $3.1 million across 5 years, with a median of $3.0 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Minority Interest dropped 2.34% in 2024, then climbed 9.63% in 2026.
• Over 5 years, Minority Interest stood at $3.1 million in 2022, then fell by 2.28% to $3.0 million in 2023, then dropped by 2.04% to $3.0 million in 2024, then climbed by 8.93% to $3.2 million in 2025, then climbed by 0.06% to $3.2 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered $3.2 million, $3.2 million, and $3.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.